Japan· JP-2133400D3034
カンレノ酸カリウム
A potassium canrenoate product containing カンレノ酸カリウム, registered in Japan by 沢井製薬, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Potassium canrenoate is registered in 9 of 19 countries.
Countries holding a registration under ATC C03DA02 (potassium canrenoate), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Potassium canrenoate · ATC C03DA02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of potassium canrenoate costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Potassium canrenoate · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- IT Italy$0.82
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- カンレノ酸カリウム
- Manufacturer
- 沢井製薬
- Country
- Japan (JP)
- ATC code
- C03DA02
- ATC class
- Potassium canrenoate
- Defined daily dose
- 0.4 g, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for potassium canrenoate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Potassium canrenoate · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C03DA02
Potassium canrenoate, as other registers publish it.
- PolandAldactoneInPharm Sp. z o.o.
- NorwayAldactoneEsteve Pharmaceuticals GmbH
- GermanyAldactoneEsteve Pharmaceuticals Gmbh
- PolandAldactoneInPharm Sp. z o.o.
- CzechiaALDACTONEESTEVE Pharmaceuticals GmbH, Berlín
- CzechiaALDACTONEESTEVE Pharmaceuticals GmbH, Berlín
- United KingdomAldactone 200mg/10ml solution for injection ampoulesImported (Germany)
- ItalyKANRENOLTEOFARMA S.R.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5d87ec7-b388-4809-a661-abd443fbe83f GET /v1/drugs/e5d87ec7-b388-4809-a661-abd443fbe83f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２００ｍｇ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2133400D3034",
"category": "注射薬",
"price_yen": 183,
"generic_name": "カンレノ酸カリウム",
"product_name_jp": null,
"therapeutic_class": "2133",
"transitional_expiry": null
}See everything about potassium canrenoate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.